A. Reia

A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis

G. Servillo, A. Carotenuto, V. Brescia Morra, 2021, Brain sciences.

Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review

V. Brescia Morra, G. Viceconte, M. Moccia, 2021, Expert opinion on drug safety.

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

J. Statland, M. Pasnoor, J. Verschuuren, 2021, The Lancet Neurology.

The Framingham cardiovascular risk score and 5‐year progression of multiple sclerosis

C. Russo, A. Carotenuto, V. Brescia Morra, 2020, European journal of neurology.

Application of the p9NORM correction method to timed neuropsychological tests in Parkinson’s disease and multiple system atrophy

G. De Michele, A. Filla, A. De Rosa, 2020, Neurological Sciences.